Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$10.65 - $18.61 $159,750 - $279,150
-15,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$14.65 - $26.07 $161,150 - $286,770
-11,000 Reduced 42.31%
15,000 $248,000
Q2 2021

Aug 16, 2021

BUY
$28.0 - $28.0 $728,000 - $728,000
26,000 New
26,000 $728,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $286M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Ghisallo Capital Management LLC Portfolio

Follow Ghisallo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghisallo Capital Management LLC with notifications on news.